220 related articles for article (PubMed ID: 10561245)
1. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer.
Barakat RR
J Clin Oncol; 1999 Jul; 17(7):1967-8. PubMed ID: 10561245
[No Abstract] [Full Text] [Related]
2. Should women receiving tamoxifen be screened for endometrial cancer? An argument for screening.
Menzin AW; Gal D; Barakat RR
Cancer Invest; 2000; 18(8):793-7. PubMed ID: 11107449
[No Abstract] [Full Text] [Related]
3. Should tamoxifen users be screened for endometrial lesions?
Neven P; Vergote I
Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
[No Abstract] [Full Text] [Related]
4. Gynecologic surveillance of women on tamoxifen: first do no harm.
Runowicz CD
J Clin Oncol; 2000 Oct; 18(20):3457-8. PubMed ID: 11032584
[No Abstract] [Full Text] [Related]
5. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
[TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer and tamoxifen.
Burke C
Clin J Oncol Nurs; 2005 Apr; 9(2):247-9. PubMed ID: 15853168
[No Abstract] [Full Text] [Related]
7. The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen.
Kazerooni T; Ghaffarpasand F; Mosalaei A; Kazerooni Y
Med Princ Pract; 2010; 19(3):222-7. PubMed ID: 20357508
[TBL] [Abstract][Full Text] [Related]
8. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
[No Abstract] [Full Text] [Related]
9. Screening recommendation for women taking tamoxifen.
Kawabata H; Ueno T
Lancet; 2001 Sep; 358(9286):1018. PubMed ID: 11593503
[No Abstract] [Full Text] [Related]
10. Tamoxifen and risk of endometrial cancer.
Marsh F; Mayfield M
Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197382
[No Abstract] [Full Text] [Related]
11. Tamoxifen and risk of endometrial cancer.
Kairies P
Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197381
[No Abstract] [Full Text] [Related]
12. Tamoxifen and risk of endometrial cancer.
Lasset C; Bonadona V; Mignotte H; Brémond A
Lancet; 2001 Jan; 357(9249):66-7. PubMed ID: 11197379
[No Abstract] [Full Text] [Related]
13. Tamoxifen and risk of endometrial cancer.
Atkins CD
Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197378
[No Abstract] [Full Text] [Related]
14. Tamoxifen and risk of endometrial cancer.
Tempfer C; Kubista E
Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197377
[No Abstract] [Full Text] [Related]
15. Tamoxifen and risk of endometrial cancer.
Narod SA; Pal T; Graham T; Mitchell M; Fyles A
Lancet; 2001 Jan; 357(9249):65-6; author reply 67. PubMed ID: 11197376
[No Abstract] [Full Text] [Related]
16. A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.
Archer DF
Menopause; 2010; 17(3):454-5. PubMed ID: 20386342
[No Abstract] [Full Text] [Related]
17. High-grade endometrial stromal sarcoma following tamoxifen treatment.
Engin H
Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
[No Abstract] [Full Text] [Related]
18. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
McCaul KA
Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
[No Abstract] [Full Text] [Related]
19. Ultrasound, tamoxifen and endometrial carcinoma.
Ghirardini G; Bianchini A; Rossi GP
Ultrasound Obstet Gynecol; 1999 May; 13(5):375-6. PubMed ID: 10380310
[No Abstract] [Full Text] [Related]
20. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
